{"id":"W4386499275","doi":"10.1038/s41591-023-02543-w","title":"Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial","year":2023,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":247,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; University of Texas Health Science Center at San Antonio; National Heart, Lung, and Blood Institute; Cure Alzheimer's Fund; Noaber Foundation; McGill University; National Heart and Lung Institute; Alzheimer's Drug Discovery Foundation; American Federation for Aging Research; U.S. Department of Veterans Affairs; U.S. Department of Health and Human Services; National Institute on Aging; Hevolution Foundation; Alzheimer's Association; GHR Foundation","keywords":"Medicine; Disease; Clinical trial; Alzheimer's disease; Oncology; Internal medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001912333,0.002218234,0.002911761,0.0005016558,0.0007225182,0.001226304,0.001014109,0.00208562,0.005319653],"category_scores_gemma":[0.001163671,0.0005790733,0.001964747,0.0004509249,0.001348512,0.001140872,0.0004273309,0.003336311,0.001154184],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009608018,"about_ca_system_score_gemma":0.002334208,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001666695,"about_ca_topic_score_gemma":0.0041256,"domain_scores_codex":[0.99946,0.0002571548,0.00003052567,0.00006675474,0.00003938429,0.0001460958],"domain_scores_gemma":[0.9991971,0.0001939384,0.0001137894,0.00006625124,0.00006305077,0.0003659427],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9038063,0.03291704,0.001096131,0.0008609461,0.001373463,0.0002463284,0.000189573,0.000575667,0.00998825,0.0004370132,0.003944581,0.0445647],"study_design_scores_gemma":[0.8564107,0.1368508,0.002778393,0.00006509278,0.000447835,0.0001016947,0.00004184884,0.0002063627,0.0007152214,0.0004422516,0.001915242,0.00002452478],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9788297,0.007628823,0.0008110593,0.001986864,0.0004790711,0.004197082,0.001960619,0.0001084834,0.00399822],"genre_scores_gemma":[0.9736366,0.008207047,0.002094355,0.0027898,0.0006121164,0.005474363,0.002616554,0.00002990234,0.004539209],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005319653,"threshold_uncertainty_score":0.01779604,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1105407341117418,"score_gpt":0.4508168843221032,"score_spread":0.3402761502103614,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}